Background We sought to determine whether there is evidence to recommend progesterone
for individuals not wishing to complete a medication abortion after taking mifepristone …

BACKGROUND: There is unsettled controversy about the respective efficacy and safety of
200 and 600 mg mifepristone in combination with two prostaglandins for the termination of …

OBJECTIVE: To summarize clinical outcomes and adverse effects of medical abortion
regimens consisting of mifepristone followed by buccal misoprostol in pregnancies through …

Objective To investigate the clinical efficacy of the combination of mifepristone and an orally
active prostaglandin, misoprostol, for early medical termination. Design Women with …

Method Literatures on the safety of medical abortion were searched in 9 databases
worldwide and 9 Chinese medical journals. Results A total of 101 articles and 1364 women …

Objective. To compare the abortifacient efficacy and side‐effects of 200 mg and 600 mg of
mifepristone, followed by gemeprost 1 mg vaginally, at 57 to 63 days' gestation. Design …

Background Mifepristone and misoprostol are recommended for second-trimester medical
abortion, but consensus is unclear on the ideal regimen. Objectives The objectives were to …

The objective of this Clinical Recommendation is to review relevant literature and provide
evidence-based recommendations for medication abortion between 14 0/7 and 27 6/7 …

Objectives To assess the clinical efficacy of mifepristone 100 mg followed two days later by
misoprostol 400 microg orally in women undergoing medical termination of pregnancy up to …

The combination of mifepristone, an antiprogesterone known in the United States as
Mifeprex (Danco Laboratories, New York, NY), and misoprostol, a pro-staglandin analogue …